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ABSTRACT
Traumatic severe brain injury is a fatal injury, with a 
mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	 million	 people	
experience	severe	brain	 injury	 in	 the	United	States.	There	




definitive	 data	 on	 the	 incidence	 of	 diabetes	 insipidus	 in	
patients	 with	 traumatic	 severe	 brain	 injury	 of	 Indonesia	
so	far.	In	this	case	report,	a	male,	45	years	old,	was	taken	
to	 the	 Emergency	 Installation	 (IRD)	 after	 experiencing	 a	
traffic	 accident	 12	 hours	 before	 being	 hospitalized.	After	
surgery,	 the	 signs	 of	 diabetes	 insipidus	 was	 presented	 by	
polyuria	of	300cc	 /	hour	urine	production	and	149mmol	 /	
L	hypernatremia,	although	the	immediate	administration	of	
desmopressin,	 the	patients	 clinical	 and	hemodynamic	was	
not	shown	any	improvements.	The	patient	passed	away	in	the	
days	five	of	treatment	in	the	Intensive	Care	Unit	(ICU).	The	
main	 treatments	 for	diabetes	 insipidus	 in	 traumatic	 severe	
brain	 injury	 are	 adequate	 rehydration	 and	 administration	
of	 desmopressin.	 Adequate	 hypovolemic,	 polyuric	 and	
hypernatremia	 corrections	 are	 the	 keys	 to	 the	 successful	
treatment	of	diabetes	insipidus.	Diabetes	insipidus	in	cases	
of	 brain	 injury	 requires	 complicated	 treatment.	Therefore,	
in	the	case	of	being	handled	improperly,	it	can	bring	death.	
Keywords:





Cedera otak berat traumatis adalah cedera fatal, dengan tingkat kematian hingga 50%. Sekitar 1,5 
juta orang mengalami cedera otak berat di Amerika Serikat. Terdapat lebih dari 50.000 kematian 
dan 500.000 insiden gangguan neurologis permanen. Sekitar 85% kematian terjadi dalam 2 minggu 
pertama setelah cedera. Salah satu komplikasi dari cedera otak yang parah adalah diabetes insipidus. 
Tidak ada data pasti tentang kejadian diabetes insipidus pada pasien dengan cedera otak traumatis 
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ABSTRACT 
Chronic Obstructive Pulmonary Disease (COPD) is a 
chronic airway inflammation with resulting progressive 
airflow limitation that has a high incidence, morbidity, 
and mortality. Roflumilast is an oral phosphodiesterase-4 
inhibitor as a therapy to decrease the risk of COPD 
exacerbations in patients with moderate-severe COPD 
with a history of chronic bronchitis. Roflumilast can be 
given orally once daily as a single or combination drug. 
It can be used as COPD moderate-severe but also more 
beneficial as COPD mild treatment. The efficacy of 
Roflumilast can prevent exacerbations of repetition and 
can fixed lung function both in terms of FEV1 and vital 
capacity to force. The incidence of side effects, which are 
diarrhea and digestive disorders. The cost-effectiveness 
showed that Quality of life patient with Roflumilast is 
better than the group without additional. This paper aimed 
to review systematically Roflumilast as COPD treatment 
for the clinical application.
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perawat 	 di	 it	 Perawatan	 Intensif	 (ICU).	 Perawatan	 utama	 untuk	 diabetes	 insipidus	 pada	
cedera	otak	berat	traumatis	adalah	rehidr si	dan	pe berian	desmopresin	yang	adekuat.	Koreksi	
hipovolemik,	 poliurik,	 dan	 hipernatremia	 yang	 adekuat	 adalah	 kunci	 keberhasilan	 pengobatan	
diabetes	 insipidus.	Diabetes	 insipidus	 dalam	 kasus	 cedera	 otak	membutuhkan	 perawatan	 yang	
rumit.	Karena	itu,	jika	ditangani	dengan	tidak	tepat,	bisa	menyebabkan	kematian.	
Kata kunci  : Diabetes insipidus, cedera otak, hipernatremia, desmopressin, ICU
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INTRODUCTION
Traumatic brain injury is a fatal injury, with 
a	 mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	
million	 people	 with	 severe	 brain	 injury	 in	
the	 United	 States	 have	 more	 than	 50,000	
deaths	 and	 500,000	 permanent	 neurological	




intracranial	 hypertension	 (Benvenga	 et	 al.,	
2000).
One	of	the	complications	of	a	severe	brain	injury	
is	 diabetes	 insipidus.	 (Agha	 and	Thompson,	
2006;	Hannon	et	al.,	2012).	Diabetes	insipidus	
is	a	disease	caused	by	 the	 lower	production,	
secretion, and function of Anti Diuretic 
Hormone	 (ADH).	 Kidney	 abnormalities	
were	 marked	 by	 the	 unresponsiveness	 of	





in Indonesia so far.
Diabetes	 insipidus	 in	 cases	 of	 brain	 injury	
requires	 complicated	 treatment.	 Diabetes	
insipidus	 can	 lead	 to	 death	 when	 handled	
improperly.	 Therefore,	 the	 authors	 are	




tr ffic	 accident	 12	 hours	 before	 bei g	
hospitalized.	Th 	patient	 is	 unconscious	 since	
the ccident occurred. First aid was given in the 
previous	health	facility;	RSUD	Tuban,	thus	the	
patient	was	referred	to	IRD	Dr.	Soetomo.
The	 patient	 has	 attach d	 a	 c llar	 brace	 at	 the	
arrival in resuscitation room of Dr. RSUD 
Soetomo.	 Responding	 to	 p in,	 with	 the	
ex mination	 of	 anisocoria	 round	 pupils	 4/3	
mm,	 both	 eye	 light	 reflexes	 were	 decreased.	
Spontaneous	 breathing	 30	 times	 per	 minut 	
presented	 with	 an	 additional	 gurgling	 breath	
with	 xygen	saturation	of	92%	using	an	oxygen	
mask	 of	 5	 liters	 per	 mi ute.	 Blood	 pressure	
110/75	mmHg	(MAP	86),	pulse	120	times	per	
minute.	 Tip	 of	 the	 extremity	wer 	warm,	 dry	
and	red	with	an	examination	of	capillary	refill	
time	 <2	 se nds.	 The	 right	 parietooccipital	
hematoma	 was	 found.	 The	 patient	 was	
immediately suctioned and oxygenated with 
Jackson	Reese	10	liters	per	minute,	a	two-lane	
intravenous	 line	 was	 attached	 and	 30°	 head-
up	 position.	 The	 patient	 was	 prepared	 to	 be	
intubated	 using	 ETT	No.7	 and	 the	 lip	 border	
was 21cm. The ventilator used PCV mode with 
RR	16,	PC	15,	trigger	2,	I:	E	1:	2,	FiO2	50%.	
INTRODUCTION
COPD (C r nic obstructive pulmonary 
disease ) is a disease f llowed by persistent ir 
flow obstruction symptoms b cause of alveolar 
abnormalities caused by me ingful exposure 
to hazardous particles or gases. COPD shoul  
be c nsidered n patie ts with dyspne , 
chronic coughing or sputum establishment, 
a h story of recurrent lower respiratory tr ct 
infections, or previous exposure to disease 
risk factors. Chronic airflow limitat on  are 
OPD characteristics d e to a combination 
of two types of small airway diseases (e.g., 
obstructive bronchiolitis) and emphysema 
(Global Initiative for Chronic Obstructive 
Lung Disease, 2019). The prevalence of 
COPD in Indonesia based on RISKESDAS 
2013 was 3,8% (Dasar, 2013).
The most common cause of COPD is cigare te 
smoke, dust, ir pollutants, and alpha-1 
antitrypsin reduction. Chronic bronchit s can 
be called a long-standing mucus buildup. The 
mucous ayer is epithelial tissue such as loose 
connective tissue, and it has a submucosa 
whose glands produce mucus naturally if 
pathogens enter the re pir tory tract. Chronic 
bronchi is occurs due to an increase in uc us 
productio  so much that it c uses narrowing 
of the re piratory tract. Usually, it occurs to 
be preceded by irritation by smoking dust, 
which is responded to by our b dy as an 
obstructive isorder narrowing the airways, 
by resulting in hypertrophy and hyperpl sia of 
t e mucous glands. If this goe  on f r a long 
time, th re will be ciliary damage (Ce ters for 
Disease Control and Prevention (US), 2010). 
Smoking can cause t ssue damage directl , 
through oxidative stress, and indirectly, by 
causing a  inflammatory response. Toxic 
substances such s those in cigarettes will 
cause inflammation of the airways, which 
will then call in inflammatory mediato s. 
COPD pat ents show mark infl mmatio  that 
correlates to the severity of the disease; the 
cytokines released can induce macrophages. 
Production of IL-8 from lveolar macrophages 
together with pulmonary epithelial cells results 
in neutrophilic infiltrates in COPD patients. 
Neutrophils, macrophages, CD4 +, CD8 + are 
inflammatory cells that are present in COPD 
pathogenesis (Agustí & Hogg, 2019).
Besides, proteases are also activated by 
neutrophils and macrophages. Protease is the 
main factor that drives the development of 
emphysema. The effect can be resisted with anti-
proteases such as α-1 antitrypsin. Antitrypsin 
deficiency α-1 can cause dangerous and early 
onset of emphysema. Arterial stiffness and 
neutrophils mediate inflammation activation 
(Berg & Wright, 2016). 
There are three pathology mechanisms in COPD 
patients; chronic bronchiolitis obstruction, 
emphysema, and mucus blockage. Activation 
of inflammatory mediators continuously 
will cause a chronic inflammatory process in 
COPD, involving the immune system is most 
evident in the bronchial wall of the airways. 
Emphysema mainly affects the small airways 
caused by an infla atory process involving 
the parenchyma and chronic bronchitis. 
Accumulation of mucus exudate in the lumen 
and an increase in bronchial wall tissue 
capacity result in small airflow obstruction 
(King, 2015). The pulmonary structural damage 
manifests inflammation in COPD induced 
by CD8+ T cell-mediated, neutrophil-based 
chronic inflammation, including interleukins, 
TNF-α, etc. (Zhang et al., 2018). The mediator 
inflammation is released by cAMP, which has 
been hydrolyzed by phosphodiesterase (PDE). 
The expression of PDE4 in the lung tissue of 
COPD patients shown PDE4 as a potential drug 
in the treatment of COPD (Zuo et al., 2019). 
Roflumilast is a selective phosphodiesterase-4 
inhibitor (PDE4) used to treat the patient with 
COPD.
The goal of therapy in stable COPD is to 
overcome and prevent acute exacerbations, 
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reduce disease progression, improve the 
patient’s physical and psychological s ate so that 
the patient can carry ut daily activities, reduce 
the number of days spent in the hospital, and 
reduce the number of deaths. The goal of therapy 
in acute exacerbations is to maintain respiratory 
function and prolong survival. The treatment 
given can be in the form of pharmacological 
treatment and non-pharmacological treatment. 
Pharmacological therapies that can be given to 
stable COP  include:
hydrolyzed by phosphodiesterase (PDE).  The expression of PDE4 in the lung tissue of COPD 
patients shown PDE4 as a potential drug in the treatment of COPD (Zuo et al., 2019). Roflumilast 
is a selective phosphodiesterase-4 inhibitor (PDE4) used to treat the patient with COPD. 
The goal of therapy in stable COPD is to overcome and prevent acute exacerbations, reduce 
diseas  progression, improve the patient's physi al and psychological state so that the patient can 
carry out daily activi ies, reduce th  number of days sp t i  the hospital, and reduce the number 
of deaths. The goal of therapy in acute exacerbations is to maintain respiratory functio  and 
prolong survival. The treatment given can be in the form of pharmacological treatment and non-
pharmacological treatment. P armacological therapies that can be given to stable COPD include: 










BETA 2- ANTAGONIS 
SHORT-ACTING (SABA) 
Fenoterol MDI √ Tablet, syrup  4-6 hours 
Levalbuterol MDI √   6-8 hours 
Salbutamol MDI & DPI √ Tablet, syrup, √ 4-6 hours 
(albuterol)   sustain release  12 hours 
     sustain 
     release 
Terbutalin DPI  Tablet √ 4-6 hours 
LONG-ACTING (LABA) 
Arformoterol  √   12 hours 
Formoterol DPI    12 hours 
Indaceterol DPI    24 hours 
Olodaterol SMI    24 hours 
Salmeterol MDI & DPI    12 hours 
ANTICOLINERGIK 
SHORT-ACTING (SAMA) 
Ipratropium bromide MDI √   6-8 hours 
Oxitropium bromide MDI    7-9 hours 
LONG-ACTING (LAMA) 
Acidinium bromide DPI, MDI    12 hours 
Glycopironium 
bromide 
DPI  solution √ 12 -24 
hours 
Tiotropium DPI, SMI    24 hours 
Umeclidnium DPI    24 hours 




SMI √   6-8 hours 
Salbutamol 
/Iprotropium 
SMI, MDI √   6-8 hours 




DPI    12 hours 
Formoterol/ 
Glycopironium 
MDI    12 hours 
Indecaterol/Glycopir 
onium 




DPI    24 hours 
Olodaterol/Tiotropiu 
m 
SMI    24 hours 
METHYLXANTIN 
Aminophilin   solution √ Up to 24 
hours 
Teofilin SR   Tablet √ Up to 24 
hours 
Table 1. The commonly drungs used in the treatment of COPD
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definitive	 data	 on	 the	 incidence	 of	 diabetes	 insipidus	 in	
patients	 with	 traumatic	 severe	 brain	 injury	 of	 Indonesia	
so	far.	In	this	case	report,	a	male,	45	years	old,	was	taken	
to	 the	 Emergency	 Installation	 (IRD)	 after	 experiencing	 a	
traffic	 accident	 12	 hours	 before	 being	 hospitalized.	After	
surgery,	 the	 signs	 of	 diabetes	 insipidus	 was	 presented	 by	
polyuria	of	300cc	 /	hour	urine	production	and	149mmol	 /	
L	hypernatremia,	although	the	immediate	administration	of	
desmopressin,	 the	patients	 clinical	 and	hemodynamic	was	
not	shown	any	improvements.	The	patient	passed	away	in	the	
days	five	of	treatment	in	the	Intensive	Care	Unit	(ICU).	The	
main	 treatments	 for	diabetes	 insipidus	 in	 traumatic	 severe	
brain	 injury	 are	 adequate	 rehydration	 and	 administration	
of	 desmopressin.	 Adequate	 hypovolemic,	 polyuric	 and	
hypernatremia	 corrections	 are	 the	 keys	 to	 the	 successful	
treatment	of	diabetes	insipidus.	Diabetes	insipidus	in	cases	
of	 brain	 injury	 requires	 complicated	 treatment.	Therefore,	
in	the	case	of	being	handled	improperly,	it	can	bring	death.	
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perawat 	 di	 it	 Perawatan	 Intensif	 (ICU).	 Perawatan	 utama	 untuk	 diabetes	 insipidus	 pada	
cedera	otak	berat	traumatis	adalah	rehidr si	dan	pe berian	desmopresin	yang	adekuat.	Koreksi	
hipovolemik,	 poliurik,	 dan	 hipernatremia	 yang	 adekuat	 adalah	 kunci	 keberhasilan	 pengobatan	
diabetes	 insipidus.	Diabetes	 insipidus	 dalam	 kasus	 cedera	 otak	membutuhkan	 perawatan	 yang	
rumit.	Karena	itu,	jika	ditangani	dengan	tidak	tepat,	bisa	menyebabkan	kematian.	
Kata kunci  : Diabetes insipidus, cedera otak, hipernatremia, desmopressin, ICU
Correspondence : yud 80987@yahoo.com
INTRODUCTION
Traumatic brain injury is a fatal injury, with 
a	 mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	
million	 people	 with	 severe	 brain	 injury	 in	
the	 United	 States	 have	 more	 than	 50,000	
deaths	 and	 500,000	 permanent	 neurological	




intracranial	 hypertension	 (Benvenga	 et	 al.,	
2000).
One	of	the	complications	of	a	severe	brain	injury	
is	 diabetes	 insipidus.	 (Agha	 and	Thompson,	
2006;	Hannon	et	al.,	2012).	Diabetes	insipidus	
is	a	disease	caused	by	 the	 lower	production,	
secretion, and function of Anti Diuretic 
Hormone	 (ADH).	 Kidney	 abnormalities	
were	 marked	 by	 the	 unresponsiveness	 of	





in Indonesia so far.
Diabetes	 insipidus	 in	 cases	 of	 brain	 injury	
requires	 complicated	 treatment.	 Diabetes	
insipidus	 can	 lead	 to	 death	 when	 handled	
improperly.	 Therefore,	 the	 authors	 are	




tr ffic	 accident	 12	 hours	 before	 bei g	
hospitalized.	Th 	patient	 is	 unconscious	 since	
the ccident occurred. First aid was given in the 
previous	health	facility;	RSUD	Tuban,	thus	the	
patient	was	referred	to	IRD	Dr.	Soetomo.
The	 patient	 has	 attach d	 a	 c llar	 brace	 at	 the	
arrival in resuscitation room of Dr. RSUD 
Soetomo.	 Responding	 to	 p in,	 with	 the	
ex mination	 of	 anisocoria	 round	 pupils	 4/3	
mm,	 both	 eye	 light	 reflexes	 were	 decreased.	
Spontaneous	 breathing	 30	 times	 per	 minut 	
presented	 with	 an	 additional	 gurgling	 breath	
with	 xygen	saturation	of	92%	using	an	oxygen	
mask	 of	 5	 liters	 per	 mi ute.	 Blood	 pressure	
110/75	mmHg	(MAP	86),	pulse	120	times	per	
minute.	 Tip	 of	 the	 extremity	wer 	warm,	 dry	
and	red	with	an	examination	of	capillary	refill	
time	 <2	 se nds.	 The	 right	 parietooccipital	
hematoma	 was	 found.	 The	 patient	 was	
immediately suctioned and oxygenated with 
Jackson	Reese	10	liters	per	minute,	a	two-lane	
intravenous	 line	 was	 attached	 and	 30°	 head-
up	 position.	 The	 patient	 was	 prepared	 to	 be	
intubated	 using	 ETT	No.7	 and	 the	 lip	 border	
was 21cm. The ventilator used PCV mode with 
RR	16,	PC	15,	trigger	2,	I:	E	1:	2,	FiO2	50%.	
Oxitropium bromide MDI    7-9 hours 
LONG-ACTING (LAMA) 
Acidinium bromide DPI, MDI    12 hours 
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hours 
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MDI     
Formoterol/Budesoni 
de 
MDI, DPI     
Formoterol/Mometas 
one 
MDI     
Salmeterol/ 
Fluticasone 
MDI, DPI     
Vilanterol/ 
Fluticasone furoate 
DPI     




DPI     
Beclometasone/Form 
oter/ Glycopironium 
MDI     
PHOSPODIESTERASE-4 INHIBITOR 
Roflumilast   Tablet   
MUCOLITIC 
Erdostine   Tablet   
*) MDI= Metered Dose Inhaler, DPI= Dry Powder Inhaler, SMI= Soft Mist Inhaler (GOLD, 2017) 
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perawat 	 di	 it	 Perawatan	 Intensif	 (ICU).	 Perawatan	 utama	 untuk	 diabetes	 insipidus	 pada	
cedera	otak	berat	traumatis	adalah	rehidr si	dan	pe berian	desmopresin	yang	adekuat.	Koreksi	
hipovolemik,	 poliurik,	 dan	 hipernatremia	 yang	 adekuat	 adalah	 kunci	 keberhasilan	 pengobatan	
diabetes	 insipidus.	Diabetes	 insipidus	 dalam	 kasus	 cedera	 otak	membutuhkan	 perawatan	 yang	
rumit.	Karena	itu,	jika	ditangani	dengan	tidak	tepat,	bisa	menyebabkan	kematian.	
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INTRODUCTION
Traumatic brain injury is a fatal injury, with 
a	 mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	
million	 people	 with	 severe	 brain	 injury	 in	
the	 United	 States	 have	 more	 than	 50,000	
deaths	 and	 500,000	 permanent	 neurological	




intracranial	 hypertension	 (Benvenga	 et	 al.,	
2000).
One	of	the	complications	of	a	severe	brain	injury	
is	 diabetes	 insipidus.	 (Agha	 and	Thompson,	
2006;	Hannon	et	al.,	2012).	Diabetes	insipidus	
is	a	disease	caused	by	 the	 lower	production,	
secretion, and function of Anti Diuretic 
Hormone	 (ADH).	 Kidney	 abnormalities	
were	 marked	 by	 the	 unresponsiveness	 of	





in Indonesia so far.
Diabetes	 insipidus	 in	 cases	 of	 brain	 injury	
requires	 complicated	 treatment.	 Diabetes	
insipidus	 can	 lead	 to	 death	 when	 handled	
improperly.	 Therefore,	 the	 authors	 are	




tr ffic	 accident	 12	 hours	 before	 bei g	
hospitalized.	Th 	patient	 is	 unconscious	 since	
the ccident occurred. First aid was given in the 
previous	health	facility;	RSUD	Tuban,	thus	the	
patient	was	referred	to	IRD	Dr.	Soetomo.
The	 patient	 has	 attach d	 a	 c llar	 brace	 at	 the	
arrival in resuscitation room of Dr. RSUD 
Soetomo.	 Responding	 to	 p in,	 with	 the	
ex mination	 of	 anisocoria	 round	 pupils	 4/3	
mm,	 both	 eye	 light	 reflexes	 were	 decreased.	
Spontaneous	 breathing	 30	 times	 per	 minut 	
presented	 with	 an	 additional	 gurgling	 breath	
with	 xygen	saturation	of	92%	using	an	oxygen	
mask	 of	 5	 liters	 per	 mi ute.	 Blood	 pressure	
110/75	mmHg	(MAP	86),	pulse	120	times	per	
minute.	 Tip	 of	 the	 extremity	wer 	warm,	 dry	
and	red	with	an	examination	of	capillary	refill	
time	 <2	 se nds.	 The	 right	 parietooccipital	
hematoma	 was	 found.	 The	 patient	 was	
immediately suctioned and oxygenated with 
Jackson	Reese	10	liters	per	minute,	a	two-lane	
intravenous	 line	 was	 attached	 and	 30°	 head-
up	 position.	 The	 patient	 was	 prepared	 to	 be	
intubated	 using	 ETT	No.7	 and	 the	 lip	 border	
was 21cm. The ventilator used PCV mode with 
RR	16,	PC	15,	trigger	2,	I:	E	1:	2,	FiO2	50%.	
Roflumilast 
The IUPAC name for Roflumilast is 3-(cyclopropylmethoxy) N-(3,5-dichloropyridin-4-yl)-4-
(difluoromethoxy) benzamide (figure 1); CAS 162401-32-3 with empirical formula 
C17H14Cl2F2N2O3 and molecular weight is 403,22. These compounds are achiral, a white 
crystalline solid, and its melting point is 158°C (Giembycz & Field, 2010). Roflumilast is a highly-
selective phosphodiesterase-4 inhibitor (PDE4) part of the PDA enzyme as a therapy for severe 
COPD with a history of chronic bronchitis and exacerbations. The mechanism of PDE4 inhibitors 
is by hydrolyzing cyclic adenosine monophosphate (cAMP) in inflammatory cells. Some anti-
inflammatory effects are produced by increasing intracellular cAMP, including decreased 
neutrophil release as an inflammatory mediator, cytokinin release, and apoptosis. Roflumilast 
ecreases allergens that cause inflammation and stabilize the inflammatory system induced by 
lipopolysaccharides. Phosphodiesterase inhibition present as anti-inflammation, anti remodeling, 
and bronchodilator effect (Zuo et al., 2019). Other studies showed that PDE4 inhibitor reduces 
pulmonary fibrosis by targeted type II AEC injury, collagen accumulation, and decreased release 
chemokine level significantly (Sisson et al., 2018). 
 
Figure 1. The Structure of  Roflumilast (Gie bycz & Field, 2010) 
Roflumilast is available in a 500 mg single dose daily tablet. Bioavailability is around 80%. 
Maximum plasma Roflumilast concentration is achieved approximately 1 hour (range 0.5-2 hours) 
after a single dose administration. At the same time, the high concentration in the form of active 
N-oxide metabolites is accomplished within 8 hours (range 4-13 hours). Roflumilast has an active 
metabolite form both have strong plasma protein bonds of around 97%. In phase I, cytochrome 
P450 (CYP) isoenzymes 1A2 and 3A4 and in phase II, conjugation reactions metabolic processes 
takes place. Roflumilast has a half-life of 17 hours. In patients with hepatic disorders, Roflumilast 
elimination disorder is likely to occur, however dosage adjustments are not required. Dose 
adjustment is also not necessary in patients with kidney disorders. Roflumilast is not supposed to 
Roflumilast
The IUPAC name for Roflumilast 
is 3-(cyclopropylmethoxy) N-(3,5-
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anti remodeling, and bronchodilator effect 
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level significantly (Sisson et al., 2018).
Roflumilast is available in a 500 mg single dose 
daily tablet. Bioavailability is around 80%. 
Maximum plasma Roflumilast concentration 
is achieved approximately 1 hour (range 0.5-2 
hours) after a single dose administration. At the 
same time, the high concentration in the form 
of active N-oxide metabolites is accomplished 
within 8 hours (range 4-13 hours). Roflumilast 
has an active metabolite form both have strong 
plasma protein bonds of around 97%. In phase 
I, cytochrome P450 (CYP) isoenzymes 1A2 
and 3A4 and in phase II, conjugation reactions 
metabolic processes takes place. Roflumilast 
has a half-life of 17 hours. In patients with 
hepatic disorders, Roflumilast elimination 
disorder is likely to occur, however dosage 
adjustments are not required. Dose adjustment 
is also not necessary in patients with kidney 
disorders. Roflumilast is not supposed to be 
given along with CYP3A4 strong inhibitors 
or dual CYP3A4 and CYP1A2 inhibitors such 
as erythromycin, ketoconazole, cimetidine or 
rifampicin. Azithromycin is a macrolide group 
that is generally given to patients with COPD 
who is only a weak inhibitor of CYP3A4 and 
interactions with Roflumilast lighter than 
erythromycin (Wedzicha et al., 2016).
Figure 1. The Structure f  Roflumilast (Giembycz & Field, 2010)
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Traumatic severe brain injury is a fatal injury, with a 
mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	 million	 people	
experience	severe	brain	 injury	 in	 the	United	States.	There	




definitive	 data	 on	 the	 incidence	 of	 diabetes	 insipidus	 in	
patients	 with	 traumatic	 severe	 brain	 injury	 of	 Indonesia	
so	far.	In	this	case	report,	a	male,	45	years	old,	was	taken	
to	 the	 Emergency	 Installation	 (IRD)	 after	 experiencing	 a	
traffic	 accident	 12	 hours	 before	 being	 hospitalized.	After	
surgery,	 the	 signs	 of	 diabetes	 insipidus	 was	 presented	 by	
polyuria	of	300cc	 /	hour	urine	production	and	149mmol	 /	
L	hypernatremia,	although	the	immediate	administration	of	
desmopressin,	 the	patients	 clinical	 and	hemodynamic	was	
not	shown	any	improvements.	The	patient	passed	away	in	the	
days	five	of	treatment	in	the	Intensive	Care	Unit	(ICU).	The	
main	 treatments	 for	diabetes	 insipidus	 in	 traumatic	 severe	
brain	 injury	 are	 adequate	 rehydration	 and	 administration	
of	 desmopressin.	 Adequate	 hypovolemic,	 polyuric	 and	
hypernatremia	 corrections	 are	 the	 keys	 to	 the	 successful	
treatment	of	diabetes	insipidus.	Diabetes	insipidus	in	cases	
of	 brain	 injury	 requires	 complicated	 treatment.	Therefore,	
in	the	case	of	being	handled	improperly,	it	can	bring	death.	
Keywords:





Cedera otak berat traumatis adalah cedera fatal, dengan tingkat kematian hingga 50%. Sekitar 1,5 
juta orang mengalami cedera otak berat di Amerika Serikat. Terdapat lebih dari 50.000 kematian 
dan 500.000 insiden gangguan neurologis permanen. Sekitar 85% kematian terjadi dalam 2 minggu 
pertama setelah cedera. Salah satu komplikasi dari cedera otak yang parah adalah diabetes insipidus. 
Tidak ada data pasti tentang kejadian diabetes insipidus pada pasien dengan cedera otak traumatis 
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be given along with CYP3A4 strong inhibitors or dual CYP3A4 and CYP1A2 inhibitors such as 
erythromycin, ketoconazole, cimetidine or rifampicin. Azithromycin is a macrolide group that is 
generally given to patients with COPD who is only a weak inhibitor of CYP3A4 and interactions 
with Roflumilast lighter than erythromycin (Wedzicha et al., 2016).  
An adverse drug reaction of Roflumilast is digestive disorders such as diarrhea, nausea, and weight 
loss. Other side effects that arise are sleep disturbance, decreased appetite, and back pain when 
compared with placebo. The general side effect of severe COPD is weight loss. This can be 
attributed to increased cAMP on lipolysis regulation. Research conducted in China states that the 
most common adverse effects related to the use of Roflumilast are upper respiratory tract 
infections, anorexia, weight loss, and diarrhea. Physical check and laboratory tests, such as 
complete blood tests, blood chemistry, u ine alysis, an  electrocardiogram, did not explain 
clinically relevant side effects (Lee t al., 2016). 
Table 2. Side Effects of Roflumilast 
 Roflumilast (n=102) Placebo (n=105) value p 
 n (%) case n (%) case 
All bad events 71 (69,6) 176 48 (45,7)  78 <0,01 
Upper respiratory tract 
infection 
21 (20,6) 24 10 (9,5) 10 0,03 
Diarrhea 14 (13,7) 14 0 0 <0,01 
Weight loss 9 (8,8) 9 1 (1,0) 1 0,01 
Anorexia 9 (8,8) 9 0 0 <0,01 
COPD exerbation 9 (8,8) 9 12 (11,4) 14 0,64 
Decreased appetite 6 (5,9) 6 1 (1,0) 1 0,06 
Gastritis 5 (4,9) 5 0 0 0,03 
Constipation 4 (3,9) 4 1 (1,0) 1 0,20 
Dizzy 4 (3,9) 4 0 0 0,06 
Rhinorrhea  4 (3,9) 4 1 (1,0) 1 0,21 
Source: Lee et al., 2016 
 
An adverse drug reaction of Roflumilast is 
digestiv  d sorders uch as diarrhea, nausea, 
and weight loss. Other side effects that arise 
are sleep disturbance, decreased appetite, and 
back pain when compared with placebo. Th  
general side effect of evere COPD is weight 
loss. This can be attributed to increased cAMP 
on lipolysis regulation. Research conducted 
in China states that the most common adverse 
effects related to the use of Roflumilast are 
upper respiratory tract infections, anorexia, 
weight loss, and diarrhea. Physical check 
and laboratory tests, such as complete blood
tests, blo d chemistry, urine analysis, and 
electrocar iogram, did not explain clinically 
relevant side effects (Lee et al., 2016).
Seven randomized controlled trials on 
th  participants’ safety tend to have more 
side effects of Roflumilast than placebo, 
gastrointestinal side effects (diarrhea, nausea, 
v miting), headaches, and weight loss. There 
was no meaningful difference in the risk of 
hear  complications or flu-like symptoms 
or upper respiratory infections. Roflumilast 
reduces moderate to severe attacks and leads 
to significant improvements in pulmonary 
function regardless of the severity of the 
disease and concomitant use of standard COPD 
therapies (Andar an et al., 2016).
Table 2. Side Effects of Roflumilast
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definitive	 data	 on	 the	 incidence	 of	 diabetes	 insipidus	 in	
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traffic	 accident	 12	 hours	 before	 being	 hospitalized.	After	
surgery,	 the	 signs	 of	 diabetes	 insipidus	 was	 presented	 by	
polyuria	of	300cc	 /	hour	urine	production	and	149mmol	 /	
L	hypernatremia,	although	the	immediate	administration	of	
desmopressin,	 the	patients	 clinical	 and	hemodynamic	was	
not	shown	any	improvements.	The	patient	passed	away	in	the	
days	five	of	treatment	in	the	Intensive	Care	Unit	(ICU).	The	
main	 treatments	 for	diabetes	 insipidus	 in	 traumatic	 severe	
brain	 injury	 are	 adequate	 rehydration	 and	 administration	
of	 desmopressin.	 Adequate	 hypovolemic,	 polyuric	 and	
hypernatremia	 corrections	 are	 the	 keys	 to	 the	 successful	
treatment	of	diabetes	insipidus.	Diabetes	insipidus	in	cases	
of	 brain	 injury	 requires	 complicated	 treatment.	Therefore,	
in	the	case	of	being	handled	improperly,	it	can	bring	death.	
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perawat 	 di	 it	 Perawatan	 Intensif	 (ICU).	 Perawatan	 utama	 untuk	 diabetes	 insipidus	 pada	
cedera	otak	berat	traumatis	adalah	rehidr si	dan	pe berian	desmopresin	yang	adekuat.	Koreksi	
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INTRODUCTION
Traumatic brain injury is a fatal injury, with 
a	 mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	
million	 people	 with	 severe	 brain	 injury	 in	
the	 United	 States	 have	 more	 than	 50,000	
deaths	 and	 500,000	 permanent	 neurological	




intracranial	 hypertension	 (Benvenga	 et	 al.,	
2000).
One	of	the	complications	of	a	severe	brain	injury	
is	 diabetes	 insipidus.	 (Agha	 and	Thompson,	
2006;	Hannon	et	al.,	2012).	Diabetes	insipidus	
is	a	disease	caused	by	 the	 lower	production,	
secretion, and function of Anti Diuretic 
Hormone	 (ADH).	 Kidney	 abnormalities	
were	 marked	 by	 the	 unresponsiveness	 of	
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Diabetes	 insipidus	 in	 cases	 of	 brain	 injury	
requires	 complicated	 treatment.	 Diabetes	
insipidus	 can	 lead	 to	 death	 when	 handled	
improperly.	 Therefore,	 the	 authors	 are	
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110/75	mmHg	(MAP	86),	pulse	120	times	per	
minute.	 Tip	 of	 the	 extremity	wer 	warm,	 dry	
and	red	with	an	examination	of	capillary	refill	
time	 <2	 se nds.	 The	 right	 parietooccipital	
hematoma	 was	 found.	 The	 patient	 was	
immediately suctioned and oxygenated with 
Jackson	Reese	10	liters	per	minute,	a	two-lane	
intravenous	 line	 was	 attached	 and	 30°	 head-
up	 position.	 The	 patient	 was	 prepared	 to	 be	
intubated	 using	 ETT	No.7	 and	 the	 lip	 border	
was 21cm. The ventilator used PCV mode with 
RR	16,	PC	15,	trigger	2,	I:	E	1:	2,	FiO2	50%.	
Efficacy and safety
The effectiveness and safety of Roflumilast 
for the administration of COPD were assessed 
in 9 phase II / IV randomized double-blind 
clinical trials. Past phase III studies, treatment 
with 500 mg Roflumilast tablets, have an 
increased pulmonary function association 
compared with placebo. Other studies also 
explained Roflumilast could fixed lung 
function in severe COPD. It could reduce 
exacerbations in moderate to severe COPD 
compared to placebo. The study showed that 
Roflumilast therapy significantly reduced the 
average incidence of repeated exacerbations 
and the length of stay in the hospital (Cilli et 
al., 2019).
The safety dan clinical effect of Roflumilast in 
the COPD patient was ev luated by a Chinese 
study group using RCT. They identified nine 
articles and 13 RCT studies showing that 
patients given with Roflumilast benefited from 
improved lung function and quality of life only 
with some side effects. Roflumilast can prevent 
exacerbation, increase lung function in terms of 
FEV 1, and forced vital capacity. As for safety, 
the overall cumulative incidence of ADR for 
the Roflumilast group was more significant 
than the placebo group (Liu et al., 2018). 


































Total cost of CHF 86.754 83.364 3390 91.470 88.161 3308 99.364 95.564 3799 
Maintenance costs, CHF 35.857 25.481 10.376 40.917 30.279 10.638 43.533 37.682 10.851 
Exerbation treatment 
costs, CHF 
2039 2.331 -292 20248.
5285 
2331 -306 2036 2331 -295 
Ex-hospital maintenance 
fees 
48.858 55.552 -6694 9.642 55.552 -7024 48.795 55.552 -6757 
Life year (LY) 9.625 9.278 0,347 6.479 9.278 0,364 9.628 9.278 0.351 
QALY 6.466 6.191 0,275 11.456 6191 0,289 6.468 6.191 0,278 
ICER,CHF per QALY 12.313   9078   13.671   
ICER,CHF per LY 9.757      10.833   
*) note: maintenance costs including medical services and COPD fees, reimbursement of costs (deduct on of 
Roflumilast fees) (Samyshkin et l., 2014) 
 
Cost-effectiveness 
The cost-effectiveness of adding therapy with Roflumilast can be seen from the magnitude 
of treatment costs and the effectiveness of the therapy as in (Table 3). From observations, show 
that the addition of Roflumilast can increase the total cost. The addition of Roflumilast for 
maintenance can lead to increased medical costs. Costs needed in patients with increased 
exacerbations, in outpatients and inpatients can reduce treatment costs. In terms of age, a little 
longer in patients using additional Roflumilast. While in terms of quality of age in patients with 
Roflumilast slightly higher than those not using additional Roflumilast. (van der Schans et al., 
2017). 
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ABSTRACT
Traumatic severe brain injury is a fatal injury, with a 
mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	 million	 people	
experience	severe	brain	 injury	 in	 the	United	States.	There	




definitive	 data	 on	 the	 incidence	 of	 diabetes	 insipidus	 in	
patients	 with	 traumatic	 severe	 brain	 injury	 of	 Indonesia	
so	far.	In	this	case	report,	a	male,	45	years	old,	was	taken	
to	 the	 Emergency	 Installation	 (IRD)	 after	 experiencing	 a	
traffic	 accident	 12	 hours	 before	 being	 hospitalized.	After	
surgery,	 the	 signs	 of	 diabetes	 insipidus	 was	 presented	 by	
polyuria	of	300cc	 /	hour	urine	production	and	149mmol	 /	
L	hypernatremia,	although	the	immediate	administration	of	
desmopressin,	 the	patients	 clinical	 and	hemodynamic	was	
not	shown	any	improvements.	The	patient	passed	away	in	the	
days	five	of	treatment	in	the	Intensive	Care	Unit	(ICU).	The	
main	 treatments	 for	diabetes	 insipidus	 in	 traumatic	 severe	
brain	 injury	 are	 adequate	 rehydration	 and	 administration	
of	 desmopressin.	 Adequate	 hypovolemic,	 polyuric	 and	
hypernatremia	 corrections	 are	 the	 keys	 to	 the	 successful	
treatment	of	diabetes	insipidus.	Diabetes	insipidus	in	cases	
of	 brain	 injury	 requires	 complicated	 treatment.	Therefore,	
in	the	case	of	being	handled	improperly,	it	can	bring	death.	
Keywords:





Cedera otak berat traumatis adalah cedera fatal, dengan tingkat kematian hingga 50%. Sekitar 1,5 
juta orang mengalami cedera otak berat di Amerika Serikat. Terdapat lebih dari 50.000 kematian 
dan 500.000 insiden gangguan neurologis permanen. Sekitar 85% kematian terjadi dalam 2 minggu 
pertama setelah cedera. Salah satu komplikasi dari cedera otak yang parah adalah diabetes insipidus. 
Tidak ada data pasti tentang kejadian diabetes insipidus pada pasien dengan cedera otak traumatis 
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Total cost of CHF 86.754 83.364 3390 91.470 88.161 3308 99.364 95.564 3799 
Maintenance costs, CHF 35.857 25.481 10.376 40.917 30.279 10.638 43.533 37.682 10.851 
Exerbation treatment 
costs, CHF 
2039 2.331 -292 20248.
5285 
2331 -306 2036 2331 -295 
Ex-hospital maintenance 
fees 
48.858 55.552 -6694 9.642 55.552 -7024 48.795 55.552 -6757 
Life year (LY) 9.625 9.278 0,347 6.479 9.278 0,364 9.628 9.278 0.351 
QALY 6.466 6.191 0,275 11.456 6191 0,289 6.468 6.191 0,278 
ICER,CHF per QALY 12.313   9078   13.671   
ICER,CHF per LY 9.757      10.833   
*) note: maintenance costs including medical services and COPD fees, reimbursement of costs (deduction of 
Roflumilast fees) (Samyshkin et al., 2014) 
 
Cost-effectiveness 
The cost-effectiveness of adding therapy with Roflumilast can be seen from the magnitude 
of treatment costs and the effectiveness of the therapy as in (Table 3). From observations, show 
that the addition of Roflumilast can increase the total cost. The addition of Roflumilast for 
maintenance can lead to increased medical costs. Costs needed in patients with increased 
exacerbatio s, in outpatients and inpatients can reduce treatment costs. In terms of age, a little 
longer in patients using additional Roflumilast. While in terms of quality of age in patients with 
Roflumilast slightly higher than those not using additional Roflumilast. (van der Schans et al., 
2017). 
 




























Combination Roflumilast with salmeterol and 
tiotropium al o gives significant results when 
compared with single drug administration. 
Patients with COPD exacerbations of 
more than 2 years rece vin  treatment with 
Roflumilast showed a very large reduction 
in the duration of xacerbations c mpared to 
placebo. The s me results were also shown 
with the use of Roflumilast combined LABA 
(long-acting beta-2 agonist) or ICS (inhalation 
corticosteroid). In DAKOTA (Daxas for COPD 
therapy) research on the impact of Roflumilast 
on the quality of life of patients with COPD, 
it shows that Rofl milast can provide a 
substantial improv ment in the quality of life 
than placebo. However, the statistics did not 
show a difference significant in terms of cost; 
the use of Roflumilast can save costs if used 
in treatment standards. Roflumilast can also 
save costs when combined with tiotropium 
and salmeterol/fluticasone or LABA or ICS. 
Glucagon-like-peptide-1 levels are increased by 
PDE4 inhibitor. Where glucagon receptors like 
peptide agonists are one treatment for diabetes. 
In a 12-week study, compared with placebo 
patients newly diagnosed with type II diabetes, 
Roflumilast can increase insulin sensitivity 
and reduce the HbA1c value (Wedzicha et al., 
2016).
Cost-effectiveness
The cost-effectiveness of adding therapy with 
Roflumilast can be seen from the magnitude 
of treatment costs and the effectiveness of the 
th rapy as i  (Table 3). From observations, show 
that the addition of R flumilast can increas  
the total cost. The addition of Roflumilast for 
maintenance can lead to increased medical 
costs. Costs needed in patients with incre sed 
exacerbations, in outpatients and inpatients ca  
reduce treatment cost . I  terms of age,  little 
longer in patients using additional Roflumilast. 
While in terms of qu lity of age in patients 
with Roflumilast slightly higher than those not 
using additional Roflumil st. (van der Schans 
et al., 2017).
Table 4. Cost Effectiveness of Roflumilast
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mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	 million	 people	
experience	severe	brain	 injury	 in	 the	United	States.	There	




definitive	 data	 on	 the	 incidence	 of	 diabetes	 insipidus	 in	
patients	 with	 traumatic	 severe	 brain	 injury	 of	 Indonesia	
so	far.	In	this	case	report,	a	male,	45	years	old,	was	taken	
to	 the	 Emergency	 Installation	 (IRD)	 after	 experiencing	 a	
traffic	 accident	 12	 hours	 before	 being	 hospitalized.	After	
surgery,	 the	 signs	 of	 diabetes	 insipidus	 was	 presented	 by	
polyuria	of	300cc	 /	hour	urine	production	and	149mmol	 /	
L	hypernatremia,	although	the	immediate	administration	of	
desmopressin,	 the	patients	 clinical	 and	hemodynamic	was	
not	shown	any	improvements.	The	patient	passed	away	in	the	
days	five	of	treatment	in	the	Intensive	Care	Unit	(ICU).	The	
main	 treatments	 for	diabetes	 insipidus	 in	 traumatic	 severe	
brain	 injury	 are	 adequate	 rehydration	 and	 administration	
of	 desmopressin.	 Adequate	 hypovolemic,	 polyuric	 and	
hypernatremia	 corrections	 are	 the	 keys	 to	 the	 successful	
treatment	of	diabetes	insipidus.	Diabetes	insipidus	in	cases	
of	 brain	 injury	 requires	 complicated	 treatment.	Therefore,	
in	the	case	of	being	handled	improperly,	it	can	bring	death.	
Keywords:





Cedera otak berat traumatis adalah cedera fatal, dengan tingkat kematian hingga 50%. Sekitar 1,5 
juta orang mengalami cedera otak berat di Amerika Serikat. Terdapat lebih dari 50.000 kematian 
dan 500.000 insiden gangguan neurologis permanen. Sekitar 85% kematian terjadi dalam 2 minggu 
pertama setelah cedera. Salah satu komplikasi dari cedera otak yang parah adalah diabetes insipidus. 
Tidak ada data pasti tentang kejadian diabetes insipidus pada pasien dengan cedera otak traumatis 
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perawat 	 di	 it	 Perawatan	 Intensif	 (ICU).	 Perawatan	 utama	 untuk	 diabetes	 insipidus	 pada	
cedera	otak	berat	traumatis	adalah	rehidr si	dan	pe berian	desmopresin	yang	adekuat.	Koreksi	
hipovolemik,	 poliurik,	 dan	 hipernatremia	 yang	 adekuat	 adalah	 kunci	 keberhasilan	 pengobatan	
diabetes	 insipidus.	Diabetes	 insipidus	 dalam	 kasus	 cedera	 otak	membutuhkan	 perawatan	 yang	
rumit.	Karena	itu,	jika	ditangani	dengan	tidak	tepat,	bisa	menyebabkan	kematian.	
Kata kunci  : Diabetes insipidus, cedera otak, hipernatremia, desmopressin, ICU
Correspondence : yud 80987@yahoo.com
INTRODUCTION
Traumatic brain injury is a fatal injury, with 
a	 mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	
million	 people	 with	 severe	 brain	 injury	 in	
the	 United	 States	 have	 more	 than	 50,000	
deaths	 and	 500,000	 permanent	 neurological	




intracranial	 hypertension	 (Benvenga	 et	 al.,	
2000).
One	of	the	complications	of	a	severe	brain	injury	
is	 diabetes	 insipidus.	 (Agha	 and	Thompson,	
2006;	Hannon	et	al.,	2012).	Diabetes	insipidus	
is	a	disease	caused	by	 the	 lower	production,	
secretion, and function of Anti Diuretic 
Hormone	 (ADH).	 Kidney	 abnormalities	
were	 marked	 by	 the	 unresponsiveness	 of	





in Indonesia so far.
Diabetes	 insipidus	 in	 cases	 of	 brain	 injury	
requires	 complicated	 treatment.	 Diabetes	
insipidus	 can	 lead	 to	 death	 when	 handled	
improperly.	 Therefore,	 the	 authors	 are	




tr ffic	 accident	 12	 hours	 before	 bei g	
hospitalized.	Th 	patient	 is	 unconscious	 since	
the ccident occurred. First aid was given in the 
previous	health	facility;	RSUD	Tuban,	thus	the	
patient	was	referred	to	IRD	Dr.	Soetomo.
The	 patient	 has	 attach d	 a	 c llar	 brace	 at	 the	
arrival in resuscitation room of Dr. RSUD 
Soetomo.	 Responding	 to	 p in,	 with	 the	
ex mination	 of	 anisocoria	 round	 pupils	 4/3	
mm,	 both	 eye	 light	 reflexes	 were	 decreased.	
Spontaneous	 breathing	 30	 times	 per	 minut 	
presented	 with	 an	 additional	 gurgling	 breath	
with	 xygen	saturation	of	92%	using	an	oxygen	
mask	 of	 5	 liters	 per	 mi ute.	 Blood	 pressure	
110/75	mmHg	(MAP	86),	pulse	120	times	per	
minute.	 Tip	 of	 the	 extremity	wer 	warm,	 dry	
and	red	with	an	examination	of	capillary	refill	
time	 <2	 se nds.	 The	 right	 parietooccipital	
hematoma	 was	 found.	 The	 patient	 was	
immediately suctioned and oxygenated with 
Jackson	Reese	10	liters	per	minute,	a	two-lane	
intravenous	 line	 was	 attached	 and	 30°	 head-
up	 position.	 The	 patient	 was	 prepared	 to	 be	
intubated	 using	 ETT	No.7	 and	 the	 lip	 border	
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According to (Samyshkin et al., 2014) (UK), it was explained that in the administration of therapy 
with LABA combined with Roflumilast compared with therapy only with LABA giving a 
difference in treatment costs of + £ 3197 with different results of +0.164 QALYs and a value of + 
0.175 Lys with an ICER value of £ 19.505 per QALY. In concluding that Roflumilast's addition 
to the PROFIT can increase the effectiveness and cost of diagnosing severe COPD. According to 
(Samyshkin et al., 2013) in Switzerland, it was explained that in the administration of therapy with 
LAMA (1) or LABA / ICS (2) or LAMA + LABA / ICS (3) combined with Roflumilast compared 
to therapy with only LAMA (1) or LABA / ICS (2) or LAMA + LABA / ICS (3) alone gives a 
difference in treatment costs of +3390 CHF (1), +3308 CHF (2), +3799 CHF (3). Give a difference 
in results +0.275 QALY (1), +0.289 QALY (2), +0.278 QALY (3). Gives ICER 12,313 CHF per 
QALY (1), ICER 11,456 CHF per QALY (2), ICER 13,671 CHF per QALY (3). It concludes that 
the addition of Roflumilast is more cost-effective in patients with frequent exacerbations.  
According to (Hertel et al., 2012b) (UK) explained that the provision of LAMA + LABA / ICS 
therapy combined with Roflumilast compared to LAMA + LABA / ICS therapy alone gives a 
difference in treatment costs of + £ 414 in patients tolerant of ICS and + £ 408 in patients intolerant 
of ICS. Furthermore provides a difference with results of +0.03 QALY in patients who are tolerant 
of ICS and +0.03 QALY in patients who are intolerant of ICS. Patients who were tolerant of ICH 
gave ICER results of £ 16,566 per QALY, whereas patients who were intolerant of ICH gave ICER 
results of £ 13,764 per QALY. The addition of Roflumilast therapy to the standard of care is a 
cost-effective way for patients with severe COPD and worsens despite the use of bronchodilators. 
According to (Nowak et al., 2013) (Germany) was explained in the administration of therapy with 
LABA + Roflumilast compared with  LABA giving a difference in + € 4500. The conclusion is 
the cost-effectiveness of adding Roflumilast to LABA therapy in patients with severe and very 
severe COPD is comparable to other therapy. Roflumilast preparations already exist in Indonesia 
with the trade name DAXAS 500 micrograms film-coated (Takeda) but there is no data on the use 
of roflumilast in Indonesia. 
 
CONCLUSION 
Roflumilast is PDE4 inhibitor as an anti-inflammation and anti-remodeling. Roflumilast can be 
used single or in combination. In a review of efficacy, it can prevent exacerbations and improve 
FEV1 and vital capacity to force. The frequent side effects of Roflumilast are diarrhea and 
(Samysh
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ABSTRACT
Traumatic severe brain injury is a fatal injury, with a 
mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	 million	 people	
experience	severe	brain	 injury	 in	 the	United	States.	There	




definitive	 data	 on	 the	 incidence	 of	 diabetes	 insipidus	 in	
patients	 with	 traumatic	 severe	 brain	 injury	 of	 Indonesia	
so	far.	In	this	case	report,	a	male,	45	years	old,	was	taken	
to	 the	 Emergency	 Installation	 (IRD)	 after	 experiencing	 a	
traffic	 accident	 12	 hours	 before	 being	 hospitalized.	After	
surgery,	 the	 signs	 of	 diabetes	 insipidus	 was	 presented	 by	
polyuria	of	300cc	 /	hour	urine	production	and	149mmol	 /	
L	hypernatremia,	although	the	immediate	administration	of	
desmopressin,	 the	patients	 clinical	 and	hemodynamic	was	
not	shown	any	improvements.	The	patient	passed	away	in	the	
days	five	of	treatment	in	the	Intensive	Care	Unit	(ICU).	The	
main	 treatments	 for	diabetes	 insipidus	 in	 traumatic	 severe	
brain	 injury	 are	 adequate	 rehydration	 and	 administration	
of	 desmopressin.	 Adequate	 hypovolemic,	 polyuric	 and	
hypernatremia	 corrections	 are	 the	 keys	 to	 the	 successful	
treatment	of	diabetes	insipidus.	Diabetes	insipidus	in	cases	
of	 brain	 injury	 requires	 complicated	 treatment.	Therefore,	
in	the	case	of	being	handled	improperly,	it	can	bring	death.	
Keywords:





Cedera otak berat traumatis adalah cedera fatal, dengan tingkat kematian hingga 50%. Sekitar 1,5 
juta orang mengalami cedera otak berat di Amerika Serikat. Terdapat lebih dari 50.000 kematian 
dan 500.000 insiden gangguan neurologis permanen. Sekitar 85% kematian terjadi dalam 2 minggu 
pertama setelah cedera. Salah satu komplikasi dari cedera otak yang parah adalah diabetes insipidus. 
Tidak ada data pasti tentang kejadian diabetes insipidus pada pasien dengan cedera otak traumatis 
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According to (Samyshkin et al., 2014) (UK), 
it was explained that in the admin stration of 
therapy with LABA combined with Roflumilast 
compared with therapy only with LABA giving 
a difference in treatment c sts of + £ 3197 with 
different results of +0.164 QALYs and a value 
of + 0.175 Lys with an ICER value f £ 19.505 
per QALY. In concludi g that Roflumilast’s 
addition to the PROFIT can increase the 
effectiveness and cost of diagnosing severe 
COPD. According to (Samyshkin et al., 2013) 
in Switzerland, it was explained that in the 
administration of the apy with LAMA (1) 
or LABA / ICS (2) or LAMA + LABA / ICS 
(3) combined with Roflumilast compared to 
therapy with only LAMA (1) or LABA / ICS 
(2) or LAMA + LABA / ICS (3) alone gives 
a difference in treatment costs of +3390 CHF 
(1), +3308 CHF (2), +3799 CHF (3). Give a 
difference in results +0.275 QALY (1), +0.289 
QALY (2), +0.278 QALY (3). Gives ICER 
12,313 CHF per QALY (1), ICER 11,456 CHF 
per QALY (2), ICER 13,671 CHF per QALY 
(3). It concludes that the addition of Roflumilast 
is more cost-effective in patients with frequent 
exacerbations. 
According to (Hertel et al., 2012b) (UK) 
explained that the provision of LAMA + LABA 
/ ICS therapy combined with Roflumilast 
compared to LAMA + LABA / ICS therapy 
alone gives a difference in treatment costs of + 
£ 414 in patients tolerant of ICS and + £ 408 in 
patients intolerant of ICS. Furthermore provides 
a difference with results of +0.03 QALY i  
patients who are tolerant of ICS and +0.03 QALY 
in patients who are intolerant of ICS. Patient  
who were tolerant of ICH gave ICER results of 
£ 16,566 per QALY, whereas patients who were 
intolerant of ICH gave ICER results of £ 13,764 
per QALY. The addition of Roflumilast therapy 
to the standard of care is a cost-effective way 
for patients with severe COPD and worsens 
despite the use of bronchodilators. According to 
(Nowak et al., 2013) (Germany) was explained 
in the administration of therapy with LABA 
+ Roflumilast compared with  LABA giving 
a difference in + € 4500. The conclusion is 
the cost-effectiveness of adding Roflumilast 
to LABA the apy in patients with severe and 
very severe COPD is comparable to other 
therapy. Roflumilast preparations already exist 
in Indonesia with the trade name DAXAS 500 
micrograms film-coated (Takeda) but there is 
no data on the use of roflumilast in Indonesia.
CONCLUSION
Roflumilast is PDE4 inhib or as an anti-
inflammation and anti-remodeling. Roflumilast 
can be used sing e or in combination. In a 
review of fficacy, it can prevent xacerbations 
and improve FEV1 and vital capacity to force. 
The frequent side effects of Roflum last are 
diarrhea and digestive disorders. The cost-
effectiveness  using Roflumila t can enhanc  
the quality of life patients compared to the 
group without additional Roflum l st.
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definitive	 data	 on	 the	 incidence	 of	 diabetes	 insipidus	 in	
patients	 with	 traumatic	 severe	 brain	 injury	 of	 Indonesia	
so	far.	In	this	case	report,	a	male,	45	years	old,	was	taken	
to	 the	 Emergency	 Installation	 (IRD)	 after	 experiencing	 a	
traffic	 accident	 12	 hours	 before	 being	 hospitalized.	After	
surgery,	 the	 signs	 of	 diabetes	 insipidus	 was	 presented	 by	
polyuria	of	300cc	 /	hour	urine	production	and	149mmol	 /	
L	hypernatremia,	although	the	immediate	administration	of	
desmopressin,	 the	patients	 clinical	 and	hemodynamic	was	
not	shown	any	improvements.	The	patient	passed	away	in	the	
days	five	of	treatment	in	the	Intensive	Care	Unit	(ICU).	The	
main	 treatments	 for	diabetes	 insipidus	 in	 traumatic	 severe	
brain	 injury	 are	 adequate	 rehydration	 and	 administration	
of	 desmopressin.	 Adequate	 hypovolemic,	 polyuric	 and	
hypernatremia	 corrections	 are	 the	 keys	 to	 the	 successful	
treatment	of	diabetes	insipidus.	Diabetes	insipidus	in	cases	
of	 brain	 injury	 requires	 complicated	 treatment.	Therefore,	
in	the	case	of	being	handled	improperly,	it	can	bring	death.	
Keywords:





Cedera otak berat traumatis adalah cedera fatal, dengan tingkat kematian hingga 50%. Sekitar 1,5 
juta orang mengalami cedera otak berat di Amerika Serikat. Terdapat lebih dari 50.000 kematian 
dan 500.000 insiden gangguan neurologis permanen. Sekitar 85% kematian terjadi dalam 2 minggu 
pertama setelah cedera. Salah satu komplikasi dari cedera otak yang parah adalah diabetes insipidus. 
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perawat 	 di	 it	 Perawatan	 Intensif	 (ICU).	 Perawatan	 utama	 untuk	 diabetes	 insipidus	 pada	
cedera	otak	berat	traumatis	adalah	rehidr si	dan	pe berian	desmopresin	yang	adekuat.	Koreksi	
hipovolemik,	 poliurik,	 dan	 hipernatremia	 yang	 adekuat	 adalah	 kunci	 keberhasilan	 pengobatan	
diabetes	 insipidus.	Diabetes	 insipidus	 dalam	 kasus	 cedera	 otak	membutuhkan	 perawatan	 yang	
rumit.	Karena	itu,	jika	ditangani	dengan	tidak	tepat,	bisa	menyebabkan	kematian.	
Kata kunci  : Diabetes insipidus, cedera otak, hipernatremia, desmopressin, ICU
Correspondence : yud 80987@yahoo.com
INTRODUCTION
Traumatic brain injury is a fatal injury, with 
a	 mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	
million	 people	 with	 severe	 brain	 injury	 in	
the	 United	 States	 have	 more	 than	 50,000	
deaths	 and	 500,000	 permanent	 neurological	




intracranial	 hypertension	 (Benvenga	 et	 al.,	
2000).
One	of	the	complications	of	a	severe	brain	injury	
is	 diabetes	 insipidus.	 (Agha	 and	Thompson,	
2006;	Hannon	et	al.,	2012).	Diabetes	insipidus	
is	a	disease	caused	by	 the	 lower	production,	
secretion, and function of Anti Diuretic 
Hormone	 (ADH).	 Kidney	 abnormalities	
were	 marked	 by	 the	 unresponsiveness	 of	





in Indonesia so far.
Diabetes	 insipidus	 in	 cases	 of	 brain	 injury	
requires	 complicated	 treatment.	 Diabetes	
insipidus	 can	 lead	 to	 death	 when	 handled	
improperly.	 Therefore,	 the	 authors	 are	




tr ffic	 accident	 12	 hours	 before	 bei g	
hospitalized.	Th 	patient	 is	 unconscious	 since	
the ccident occurred. First aid was given in the 
previous	health	facility;	RSUD	Tuban,	thus	the	
patient	was	referred	to	IRD	Dr.	Soetomo.
The	 patient	 has	 attach d	 a	 c llar	 brace	 at	 the	
arrival in resuscitation room of Dr. RSUD 
Soetomo.	 Responding	 to	 p in,	 with	 the	
ex mination	 of	 anisocoria	 round	 pupils	 4/3	
mm,	 both	 eye	 light	 reflexes	 were	 decreased.	
Spontaneous	 breathing	 30	 times	 per	 minut 	
presented	 with	 an	 additional	 gurgling	 breath	
with	 xygen	saturation	of	92%	using	an	oxygen	
mask	 of	 5	 liters	 per	 mi ute.	 Blood	 pressure	
110/75	mmHg	(MAP	86),	pulse	120	times	per	
minute.	 Tip	 of	 the	 extremity	wer 	warm,	 dry	
and	red	with	an	examination	of	capillary	refill	
time	 <2	 se nds.	 The	 right	 parietooccipital	
hematoma	 was	 found.	 The	 patient	 was	
immediately suctioned and oxygenated with 
Jackson	Reese	10	liters	per	minute,	a	two-lane	
intravenous	 line	 was	 attached	 and	 30°	 head-
up	 position.	 The	 patient	 was	 prepared	 to	 be	
intubated	 using	 ETT	No.7	 and	 the	 lip	 border	
was 21cm. The ventilator used PCV mode with 
RR	16,	PC	15,	trigger	2,	I:	E	1:	2,	FiO2	50%.	
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ABSTRACT
Traumatic severe brain injury is a fatal injury, with a 
mortality	 rate	 of	 up	 to	 50%.	 About	 1.5	 million	 people	
experience	severe	brain	 injury	 in	 the	United	States.	There	




definitive	 data	 on	 the	 incidence	 of	 diabetes	 insipidus	 in	
patients	 with	 traumatic	 severe	 brain	 injury	 of	 Indonesia	
so	far.	In	this	case	report,	a	male,	45	years	old,	was	taken	
to	 the	 Emergency	 Installation	 (IRD)	 after	 experiencing	 a	
traffic	 accident	 12	 hours	 before	 being	 hospitalized.	After	
surgery,	 the	 signs	 of	 diabetes	 insipidus	 was	 presented	 by	
polyuria	of	300cc	 /	hour	urine	production	and	149mmol	 /	
L	hypernatremia,	although	the	immediate	administration	of	
desmopressin,	 the	patients	 clinical	 and	hemodynamic	was	
not	shown	any	improvements.	The	patient	passed	away	in	the	
days	five	of	treatment	in	the	Intensive	Care	Unit	(ICU).	The	
main	 treatments	 for	diabetes	 insipidus	 in	 traumatic	 severe	
brain	 injury	 are	 adequate	 rehydration	 and	 administration	
of	 desmopressin.	 Adequate	 hypovolemic,	 polyuric	 and	
hypernatremia	 corrections	 are	 the	 keys	 to	 the	 successful	
treatment	of	diabetes	insipidus.	Diabetes	insipidus	in	cases	
of	 brain	 injury	 requires	 complicated	 treatment.	Therefore,	
in	the	case	of	being	handled	improperly,	it	can	bring	death.	
Keywords:





Cedera otak berat traumatis adalah cedera fatal, dengan tingkat kematian hingga 50%. Sekitar 1,5 
juta orang mengalami cedera otak berat di Amerika Serikat. Terdapat lebih dari 50.000 kematian 
dan 500.000 insiden gangguan neurologis permanen. Sekitar 85% kematian terjadi dalam 2 minggu 
pertama setelah cedera. Salah satu komplikasi dari cedera otak yang parah adalah diabetes insipidus. 
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